Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research- Mobile, Alabama

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity's research site in Mobile frequently conducts clinical trials related, but not limited to, Infectious Diseases, Women’s Health, and Pulmonology. Acquired by Velocity in 2022, this location was founded in 2019 as part of MedPharmics.Located in Spring Hill Medical Center, a building filled with a wide variety of doctor’s offices, the site is easily accessible to thousands of patients. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Mobile team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Research institute

Business Subcategory

Source: Human-provided. Research institute
Source: Trial-derived.
17Total Trials
Source: Trial-derived.
1Recruiting Trials
Source: Trial-derived.
5Active Trials
Source: Trial-derived.
9Completed Trials
Source: Trial-derived.
21Unique Conditions
Source: Trial-derived.
16Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Asthma (2)Source: Trial-derived. Contraception (2)Source: Trial-derived. Bladder Pain Syndrome (1)Source: Trial-derived. Chronic Pancreatitis (1)Source: Trial-derived. Chronic Spontaneous Urticaria (1)Source: Trial-derived. COVID-19 (1)Source: Trial-derived. Cystic Fibrosis (1)Source: Trial-derived. Cystic Fibrosis (CF) (1)

Sponsors

Source: Trial-derived. Pfizer (4)Source: Trial-derived. AbbVie (2)Source: Trial-derived. ModernaTX, Inc. (2)Source: Trial-derived. Armata Pharmaceuticals, Inc. (1)Source: Trial-derived. BioNTech SE (1)Source: Trial-derived. Currax Pharmaceuticals (1)Source: Trial-derived. DevPro Biopharma (1)Source: Trial-derived. Evommune, Inc. (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic source (eSource) system

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Cardiac monitoring
Source: AI-inferred. Hemagglutination inhibition (HAI) assay
Source: AI-inferred. Obstetric delivery and newborn assessment facility
Source: AI-inferred. Vaccine immunogenicity serology